Enbo Ma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Enbo Ma has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Fábio Martins Laginha
Department of Breast Surgery, Hospital Pérola Byington, São Paulo, Brazil
1 shared publication - Gerson Shigeaki Hamada
Nikkei Disease Prevention Center, São Paulo, Brazil
1 shared publication - Ines Nobuko Nishimoto
Department of Head and Neck Surgery and Otorhinolaryngology, Cancer Hospital AC Camargo, 01509-010 São Paulo, Brazil
1 shared publication - Ishihara Junko
Epidemiology and Prevention Division, Research Center for Cancer Prevention and Screening, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan
1 shared publication - Juvenal Mottola Junior
Department of Breast Surgery, Hospital Pérola Byington, São Paulo, Brazil
1 shared publication - Motoki Iwasaki
Division of Epidemiology, National Cancer Center Institute for Cancer Control, Tokyo, Japan
1 shared publication
Latest Publications
- Open Access
- 24 April 2009
- Published by Springer Nature in BMC Cancer
- Vol. 9 (1) , 122
Dietary intake of folate, vitamin B6, and vitamin B12, genetic polymorphism of related enzymes, and risk of breast cancer: a case-control study in Brazilian women
Background: Several studies have determined that dietary intake of B vitamins may be associated with breast cancer risk as a result of interactions between5,10-methylenetetrahydrofolate reductase (MTHFR)andmethionine synthase(MTR) in the one-carbon metabolism pathway. However, the association between B vitamin intake and breast cancer risk in Brazilian women in particular has not yet been investigated.Methods: A case-control study was conducted in São Paulo, Brazil, with 458 age-matched pairs of Brazilian women. Energy-adjusted intakes of folate, vitamin B6, and vitamin B12were derived from a validated Food Frequency Questionnaire (FFQ). Genotyping was completed forMTHFRA1298C and C677T, andMTRA2756G polymorphisms. A logistical regression model was used to calculate odds ratios (ORs) and 95% confidence intervals (95% CIs).Results: Neither dietary intake of folate, vitamin B6, or vitamin B12norMTHFRpolymorphisms were independently associated with breast cancer risk. Analysis stratified by menopausal status showed a significant association between placement in the highest tertile of folate intake and risk of breast cancer in premenopausal women (OR = 2.17, 95% CI: 1.23–3.83;Ptrend= 0.010). TheMTR2756GG genotype was associated with a higher risk of breast cancer than the 2756AA genotype (OR = 1.99, 95% CI = 1.01–3.92;Ptrend= 0.801), and statistically significant interactions with regard to risk were observed between theMTHFRA1298C polymorphism and folate (P = 0.024) or vitamin B6(P = 0.043), and between theMTHFRC677T polymorphism and folate (P = 0.043) or vitamin B12(P = 0.022).Conclusion: MTHFRpolymorphisms and dietary intake of folate, vitamin B6, and vitamin B12had no overall association with breast cancer risk. However, increased risk was observed in total women with theMTR2756GG genotype and in premenopausal women with high folate intake. These findings, as well as significant interactions betweenMTHFRpolymorphisms and B vitamins, warrant further investigation.
- 24 April 2009
- Published by Springer Nature in BMC Cancer
- Vol. 9 (1) , 122
Open AccessDietary intake of folate, vitamin B6, and vitamin B12, genetic polymorphism of related enzymes, and risk of breast cancer: a case-control study in Brazilian women
Background: Several studies have determined that dietary intake of B vitamins may be associated with breast cancer risk as a result of interactions between5,10-methylenetetrahydrofolate reductase (MTHFR)andmethionine synthase(MTR) in the one-carbon metabolism pathway. However, the association between B vitamin intake and breast cancer risk in Brazilian women in particular has not yet been investigated.Methods: A case-control study was conducted in São Paulo, Brazil, with 458 age-matched pairs of Brazilian women. Energy-adjusted intakes of folate, vitamin B6, and vitamin B12were derived from a validated Food Frequency Questionnaire (FFQ). Genotyping was completed forMTHFRA1298C and C677T, andMTRA2756G polymorphisms. A logistical regression model was used to calculate odds ratios (ORs) and 95% confidence intervals (95% CIs).Results: Neither dietary intake of folate, vitamin B6, or vitamin B12norMTHFRpolymorphisms were independently associated with breast cancer risk. Analysis stratified by menopausal status showed a significant association between placement in the highest tertile of folate intake and risk of breast cancer in premenopausal women (OR = 2.17, 95% CI: 1.23–3.83;Ptrend= 0.010). TheMTR2756GG genotype was associated with a higher risk of breast cancer than the 2756AA genotype (OR = 1.99, 95% CI = 1.01–3.92;Ptrend= 0.801), and statistically significant interactions with regard to risk were observed between theMTHFRA1298C polymorphism and folate (P = 0.024) or vitamin B6(P = 0.043), and between theMTHFRC677T polymorphism and folate (P = 0.043) or vitamin B12(P = 0.022).Conclusion: MTHFRpolymorphisms and dietary intake of folate, vitamin B6, and vitamin B12had no overall association with breast cancer risk. However, increased risk was observed in total women with theMTR2756GG genotype and in premenopausal women with high folate intake. These findings, as well as significant interactions betweenMTHFRpolymorphisms and B vitamins, warrant further investigation.